Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0330
+0.0070 (26.92%)
Aug 10, 2026, 3:55 PM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 7.42 million as of August 10, 2026. Its market cap has decreased by -59.23% in one year.
Market Cap
7.42M
Enterprise Value
5.98M
Revenue
410.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 7.42M, a decrease of -91.71%. That is a compound annual growth rate of -42.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 7.42M | -44.12% |
| Dec 30, 2025 | 13.27M | 1.87% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 63.39B |
| Sigma Healthcare | 34.39B |
| Pro Medicus | 18.40B |
| Sonic Healthcare | 10.99B |
| Bio-Gene Technology | 8.88M |
| CurveBeam AI | 8.60M |
| Invex Therapeutics | 8.27M |
| Careteq | 8.02M |